Evidence map›Paper›PMID 41982840›Full record

ArticleJournal of current ophthalmology

Retinal Predictors of Visual Outcome and Recurrence in Naïve Myopic Choroidal Neovascularization Patients.

Leandro Inferrera, Andrea Gaggino, Alessandro Drigo, Rossella Agolini, Davide Caltagirone, Elena Verdimonti, Daniele Tognetto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leandro InferreraDepartment of Medical, Surgical Sciences and Health, University of Trieste, Trieste, TS, Italy.
Andrea GagginoDepartment of Medical, Surgical Sciences and Health, University of Trieste, Trieste, TS, Italy.
Alessandro DrigoDepartment of Medical, Surgical Sciences and Health, University of Trieste, Trieste, TS, Italy.
Rossella AgoliniDepartment of Medical, Surgical Sciences and Health, University of Trieste, Trieste, TS, Italy.
Davide CaltagironeDepartment of Medical, Surgical Sciences and Health, University of Trieste, Trieste, TS, Italy.
Elena VerdimontiDepartment of Medical, Surgical Sciences and Health, University of Trieste, Trieste, TS, Italy.
Daniele TognettoDepartment of Medical, Surgical Sciences and Health, University of Trieste, Trieste, TS, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To identify predictive factors for recurrence and to assess variables influencing visual acuity over time. Methods: This retrospective study analyzed 137 eyes of 128 patients with myopic choroidal neovascularization (mCNV) treated with intravitreal antivascular endothelial growth factor injections (ranibizumab or aflibercept) between June 2017 and June 2022, with a minimum 12-month follow-up. The study cohort was divided into two groups: The recurrence (R) group, which included eyes that experienced a recurrence of mCNV activity, and the nonrecurrence (NR) group, which included eyes without recurrence. Results: The R group consisted of 56 eyes, whereas the NR group included 81 eyes. Recurrence was significantly associated with lower baseline best-corrected visual acuity (BCVA) (odds ratio [OR]: 1.95; Conclusions: Baseline clinical and imaging biomarkers are significantly associated with both recurrence risk and visual outcomes in mCNV. Early identification of these predictive factors may guide treatment strategies and optimize long-term visual prognosis.

Indexed as

Antivascular endothelial growth factorMyopic choroidal neovascularizationPathological myopiaPrognostic factorsSpectral domain optical coherence tomography

Identifiers

PMID41982840
PMCPMC13075926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.